The post Prenetics Halts Bitcoin Buying Plan Months After $48M Raise appeared on BitcoinEthereumNews.com. Prenetics halted its Bitcoin accumulation plan less thanThe post Prenetics Halts Bitcoin Buying Plan Months After $48M Raise appeared on BitcoinEthereumNews.com. Prenetics halted its Bitcoin accumulation plan less than

Prenetics Halts Bitcoin Buying Plan Months After $48M Raise

  • Prenetics halted its Bitcoin accumulation plan less than three months after raising $48 million.
  • Capital is now fully redirected toward scaling IM8, a supplements brand.
  • Existing BTC holdings remain untouched, with 510 BTC retained as a passive reserve asset.

Prenetics Global has abandoned its plan to aggressively accumulate Bitcoin, less than three months after raising $48 million in an equity round that was partly designed to fund a crypto treasury.

The Nasdaq-listed health sciences firm said it will no longer pursue additional Bitcoin purchases, pulling away from a strategy it only formally embraced earlier this year.

The decision follows a prolonged period of weakness in the crypto market, which has put digital asset treasury models that gained popularity during the first half of the year, at risk.

Bitcoin prices have fallen substantially since Prenetics, backed by star David Beckham, announced the funding round in October.

Capital Redirected Toward IM8 Growth

Rather than continue building a BTC position, the company is redirecting its focus toward scaling its consumer health brand, IM8.

Management describes IM8 as one of the fastest-growing supplement brands ever, with more than $100 million in annualized recurring revenue achieved within its first year of launch.

The firm now views IM8 as a rare execution opportunity with clearer revenue visibility and lower balance sheet volatility than digital asset accumulation.

With over $70 million in cash and equivalents, Prenetics believes concentrating resources on product expansion and global distribution offers a more reliable path to long-term shareholder value.

However, Prenetics will continue to hold its existing BTC reserves. The company currently owns 510 BTC, which it intends to keep as a reserve asset rather than actively trade or expand.

No additional capital, new or existing, will be allocated toward Bitcoin buying under the revised strategy. This shift effectively freezes the crypto treasury experiment without forcing a sell-off.

Related : Strategy Adds 1,229 BTC as Bitcoin Consolidates Near $87K

Japanese Bitcoin giant Metaplanet spent 2025 buying BTC whenever it got a chance. According to chief executive Simon Gerovich, the Tokyo-listed company bought 4,279 BTC during the fourth quarter.

It is clear that smaller digital asset treasury firms are more affected by the Bitcoin pullback than bigger firms like Metaplanet, which have even taken loans to buy BTC.

Related: Bitcoin Price Prediction: BTC Holds $84,000 Support But ETF Flows Block Breakout

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

Source: https://coinedition.com/beckham-backed-prenetics-drops-bitcoin-accumulation-to-focus-on-im8-growth/

Market Opportunity
Nowchain Logo
Nowchain Price(NOW)
$0.00146
$0.00146$0.00146
-7.59%
USD
Nowchain (NOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.